pegunigalsidase alfa
pegunigalsidase alfa is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including ELFABRIO. Available dosage form: injection, solution, concentrate.
Drug Details
- Generic Name
- pegunigalsidase alfa
- Brand Names
- ELFABRIO
- Application Number
- BLA761161
- Sponsor
- Chiesi USA, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- PEGUNIGALSIDASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease. ELFABRIO is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme indicated for the treatment of adults with confirmed Fabry disease. ( 1 )